MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
Interpace Biosciences Cash and Cash Equivalents 2011-2026 | IDXG
Annual Cash and Cash Equivalents Interpace Biosciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.46 M | 3.5 M | 4.83 M | 2.67 M | 2.77 M | 2.32 M | 6.07 M | 15.2 M | 602 K | 8.31 M | 23.1 M | 45.6 M | 52.8 M | 64.3 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 64.3 M | 602 K | 16.7 M |
Quarterly Cash and Cash Equivalents Interpace Biosciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.42 M | 502 K | 1.2 M | 1.46 M | 1.4 M | 500 K | 2.81 M | 3.5 M | 5.03 M | 5.08 M | 5.6 M | 4.83 M | 6.31 M | 2.12 M | 3.1 M | 2.67 M | 3.43 M | 3.79 M | 2.84 M | 2.77 M | 2.77 M | 2.77 M | 2.77 M | 2.32 M | 2.32 M | 2.32 M | 2.32 M | 6.07 M | 6.07 M | 6.07 M | 6.07 M | 15.2 M | 15.2 M | 15.2 M | 15.2 M | 602 K | 602 K | 602 K | 602 K | 8.31 M | 8.31 M | 8.31 M | 8.31 M | 23.1 M | 23.1 M | 23.1 M | 23.1 M | 45.6 M | 45.6 M | 45.6 M | 45.6 M | 52.8 M | 52.8 M | 52.8 M | 52.8 M | 64.3 M | 64.3 M | 64.3 M | 64.3 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 64.3 M | 500 K | 16 M |
Cash and Cash Equivalents of other stocks in the Diagnostics research industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Anixa Biosciences
ANIX
|
1.24 M | $ 3.05 | -1.62 % | $ 99 K |  USA |
|
Akumin
AKU
|
59.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
13.3 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
12.9 M | - | -13.05 % | $ 7.29 M | USA |
 |
Brainsway Ltd.
BWAY
|
69.3 M | $ 23.39 | -2.74 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
1.9 B | $ 34.5 | 2.16 % | $ 371 M |  China |
 |
Accelerate Diagnostics
AXDX
|
34.9 M | - | -61.36 % | $ 2.46 M | USA |
 |
BioNano Genomics
BNGO
|
9.17 M | $ 1.24 | -15.65 % | $ 1.58 M | USA |
 |
Castle Biosciences
CSTL
|
120 M | $ 39.73 | 1.44 % | $ 1.1 B | USA |
 |
Check-Cap Ltd.
CHEK
|
7.7 M | - | - | $ 9.42 M | Israel |
 |
Chembio Diagnostics
CEMI
|
18.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
14.9 M | - | - | $ 79.8 M | USA |
 |
Danaher Corporation
DHR
|
2.08 B | $ 219.15 | -0.14 % | $ 160 B | USA |
 |
Exact Sciences Corporation
EXAS
|
601 M | $ 102.44 | 0.13 % | $ 19 B | USA |
 |
DermTech
DMTK
|
36.7 M | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
6.66 B | - | - | $ 399 M | China |
 |
Fulgent Genetics
FLGT
|
55.1 M | $ 26.14 | -0.38 % | $ 790 M | USA |
 |
Genetic Technologies Limited
GENE
|
11.7 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
176 M | - | 0.12 % | $ 80.1 M | China |
 |
Guardant Health
GH
|
526 M | $ 113.64 | 2.86 % | $ 13.9 B | USA |
 |
DexCom
DXCM
|
566 M | $ 73.4 | -0.81 % | $ 28.3 B | USA |
 |
CareDx, Inc
CDNA
|
82.2 M | $ 20.69 | -0.53 % | $ 1.11 B | USA |
 |
Celcuity
CELC
|
22.5 M | $ 109.42 | -2.41 % | $ 4.32 B | USA |
 |
DarioHealth Corp.
DRIO
|
36.8 M | $ 9.94 | -3.54 % | $ 282 M | Israel |
 |
Enzo Biochem
ENZ
|
52.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Lantheus Holdings
LNTH
|
913 M | $ 66.97 | 0.44 % | $ 4.63 B | USA |
 |
Heska Corporation
HSKA
|
157 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
12.2 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
1.13 B | $ 145.56 | -2.76 % | $ 23.1 B | USA |
 |
NeoGenomics
NEO
|
367 M | $ 12.04 | -2.9 % | $ 1.52 B | USA |
 |
QIAGEN N.V.
QGEN
|
598 M | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
1.7 B | $ 231.17 | -1.83 % | $ 41.9 B | USA |
 |
Charles River Laboratories International
CRL
|
195 M | $ 210.54 | -0.57 % | $ 10.8 B | USA |
 |
Medpace Holdings
MEDP
|
669 M | $ 585.64 | -1.25 % | $ 18.1 B | USA |
 |
Personalis
PSNL
|
91.4 M | $ 9.43 | -5.42 % | $ 559 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
549 M | $ 186.85 | 2.49 % | $ 20.7 B | USA |
|
Biodesix
BDSX
|
26.2 M | $ 9.94 | 2.85 % | $ 1.29 B | USA |
 |
Motus GI Holdings
MOTS
|
4.96 M | - | -34.28 % | $ 263 K | Israel |
 |
Precipio
PRPO
|
1.5 M | $ 24.53 | 1.11 % | $ 31.8 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.52 B | $ 271.48 | 0.62 % | $ 22.8 B | USA |
 |
Mettler-Toledo International
MTD
|
59.4 M | $ 1 381.85 | -0.79 % | $ 29.3 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
752 M | $ 180.78 | -2.75 % | $ 14.9 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
288 M | $ 674.26 | -0.36 % | $ 55.6 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.4 B | $ 28.74 | -1.74 % | $ 20 B | Niderland |
 |
Agilent Technologies
A
|
1.48 B | $ 133.38 | 0.11 % | $ 40.5 B | USA |
 |
Biomerica
BMRA
|
2.4 M | $ 2.36 | -1.26 % | $ 5.42 M | USA |